Literature DB >> 19419945

IFN-gamma, IL-5, IL-6 and IgE in patients infected with Giardia intestinalis.

Joanna Matowicka-Karna1, Violetta Dymicka-Piekarska, Halina Kemona.   

Abstract

The immune system, its cellular and humoral response, is engaged by the host organism to fight against parasitic infections. The study group consisted of 90 patients (58 women and 32 men), aged 18-72 years, infected with G. intestinalis. The diagnosis was established based on laboratory investigations (stool examination, choloscopy, GSA-65). Blood for analysis was collected before (G1), and 2 weeks (G2) and 2 months (G3) after antiparasitic treatment. Control group consisted of 40 healthy subjects (22 women and 18 men), aged 20-45 years. The concentrations of IgE were assayed using a set of VIDAS (bioMerieux) and the concentrations of IL-5, IL-6, IFN-gamma were determined using a set of Quantikine human (R&D Systems). It was revealed that in giardiosis the concentrations of IgE and IL-5 in blood serum were twice as high, the concentration of IL-6 was two and a half times higher and the concentration of IFN-gamma was almost four times higher as compared to healthy controls.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19419945     DOI: 10.2478/v10042-009-0013-3

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  17 in total

1.  Adaptive immune response in symptomatic and asymptomatic enteric protozoal infection: evidence for a determining role of parasite genetic heterogeneity in host immunity to human giardiasis.

Authors:  Zahra Babaei; Najmeh Malihi; Naser Zia-Ali; Iraj Sharifi; Mohammad A Mohammadi; Martin F Kagnoff; Lars Eckmann; Steven M Singer; Shahram Solaymani-Mohammadi
Journal:  Microbes Infect       Date:  2016-07-08       Impact factor: 2.700

Review 2.  Giardia duodenalis: the double-edged sword of immune responses in giardiasis.

Authors:  Shahram Solaymani-Mohammadi; Steven M Singer
Journal:  Exp Parasitol       Date:  2010-06-18       Impact factor: 2.011

3.  Giardia duodenalis: dendritic cell defects in IL-6 deficient mice contribute to susceptibility to intestinal infection.

Authors:  Joel D Kamda; Theodore E Nash; Steven M Singer
Journal:  Exp Parasitol       Date:  2012-01-10       Impact factor: 2.011

Review 4.  The Intersection of Immune Responses, Microbiota, and Pathogenesis in Giardiasis.

Authors:  Marc Y Fink; Steven M Singer
Journal:  Trends Parasitol       Date:  2017-08-19

5.  Antagonism between two intestinal parasites in humans: the importance of co-infection for infection risk and recovery dynamics.

Authors:  Aaron D Blackwell; Melanie Martin; Hillard Kaplan; Michael Gurven
Journal:  Proc Biol Sci       Date:  2013-08-28       Impact factor: 5.349

6.  Giardia lamblia: identification of molecules that contribute to direct mast cell activation.

Authors:  Samira Muñoz-Cruz; Argelia Gomez-García; Félix Matadamas-Martínez; Juan A Alvarado-Torres; Patricia Meza-Cervantez; Lourdes Arriaga-Pizano; Lilián Yépez-Mulia
Journal:  Parasitol Res       Date:  2018-06-02       Impact factor: 2.289

7.  Parasite infection and tuberculosis disease among children: a case-control study.

Authors:  Molly F Franke; Hernán Del Castillo; Ynés Pereda; Leonid Lecca; Jhoelma Fuertes; Luz Cárdenas; Mercedes C Becerra; Jaime Bayona; Megan Murray
Journal:  Am J Trop Med Hyg       Date:  2013-12-30       Impact factor: 2.345

8.  Control of Giardiasis by Interleukin-17 in Humans and Mice--Are the Questions All Answered?

Authors:  Steven M Singer
Journal:  Clin Vaccine Immunol       Date:  2015-11-18

9.  Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice.

Authors:  Tzu-Ling Chen; Shin Chen; Hsiu-Wei Wu; Tsung-Chun Lee; Yen-Zhen Lu; Li-Ling Wu; Yen-Hsuan Ni; Chin-Hung Sun; Wei-Hsuan Yu; Andre G Buret; Linda Chia-Hui Yu
Journal:  Gut Pathog       Date:  2013-08-30       Impact factor: 4.181

Review 10.  Probiotics in the management of Giardia duodenalis: an update on potential mechanisms and outcomes.

Authors:  Nasrin Dashti; Mitra Zarebavani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-29       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.